Concentrix (CNXC)
(Delayed Data from NSDQ)
$47.94 USD
+1.92 (4.17%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $47.93 -0.01 (-0.02%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth A Momentum A VGM
Cash flow Statements
Fiscal Year End for Concentrix Corporation falls in the month of November.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 313.84 | 435.64 | 405.58 | 164.81 | 117.16 |
Depreciation/Amortization & Depletion | 394.38 | 309.54 | 277.18 | 276.57 | 305.78 |
Net Change from Assets/Liabilities | -10.66 | -165.02 | -165.46 | 37.57 | -10.76 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -19.56 | 20.56 | -3.12 | 28.66 | 37.55 |
Net Cash From Operating Activities | 678.01 | 600.72 | 514.18 | 507.61 | 449.74 |
Property & Equipment | -180.53 | -140.02 | -149.08 | -171.33 | -111.12 |
Acquisition/ Disposition of Subsidiaries | -1,914.08 | -1,698.26 | 70.43 | -5.56 | -9.43 |
Investments | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -14.63 | 0.00 | 0.00 | 67.68 | -30.47 |
Net Cash from Investing Activities | -2,109.24 | -1,839.28 | -78.65 | -109.22 | -151.01 |
Uses of Funds
11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -73.99 | -126.21 | -43.79 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 1,983.99 | 1,426.50 | -345.00 | -326.70 | -339.64 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -63.50 | -53.43 | -13.08 | 0.00 | 0.00 |
Other Financing Activities | -43.83 | -9.33 | 0.00 | -8.52 | 0.00 |
Net Cash from Financing Activities | 1,802.68 | 1,237.53 | -401.87 | -335.22 | -339.64 |
Effect of Exchange Rate Changes | -12.42 | -24.52 | -7.00 | 9.66 | -3.45 |
Net Change In Cash & Equivalents | 359.02 | -25.55 | 26.66 | 72.84 | -44.37 |
Cash at Beginning of Period | 157.46 | 183.01 | 156.35 | 83.51 | 127.88 |
Cash at End of Period | 516.49 | 157.46 | 183.01 | 156.35 | 83.51 |
Diluted Net EPS | 5.70 | 8.28 | 7.70 | 3.19 | NA |
Fiscal Year End for Concentrix Corporation falls in the month of November.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 118.94 | 52.10 | 313.84 | 244.36 |
Depreciation/Amortization & Depletion | NA | 373.80 | 189.69 | 394.38 | 232.83 |
Net Change from Assets/Liabilities | NA | -279.08 | -275.64 | -10.66 | -48.43 |
Net Cash from Discontinued Operations | NA | NA | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -22.19 | -13.02 | -19.56 | 19.99 |
Net Cash From Operating Activities | NA | 191.47 | -46.87 | 678.01 | 448.74 |
Property & Equipment | NA | -116.15 | -56.06 | -180.53 | -115.72 |
Acquisition/ Disposition of Subsidiaries | NA | -4.50 | -4.50 | -1,914.08 | 0.00 |
Investments | NA | NA | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | NA | 0.00 | -14.63 | 0.00 |
Net Cash from Investing Activities | NA | -120.65 | -60.56 | -2,109.24 | -115.72 |
Uses of Funds
8/31/2024 | 5/31/2024 | 2/29/2024 | 11/30/2023 | 8/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -62.58 | -22.16 | -73.99 | -45.83 |
Issuance (Repayment) of Debt | NA | -25.81 | 95.11 | 1,983.99 | 1,755.49 |
Increase (Decrease) Short-Term Debt | NA | NA | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -40.96 | -20.61 | -63.50 | -42.88 |
Other Financing Activities | NA | -53.93 | -37.89 | -43.83 | -30.52 |
Net Cash from Financing Activities | NA | -183.28 | 14.44 | 1,802.68 | 1,636.26 |
Effect of Exchange Rate Changes | NA | -5.98 | -5.54 | -12.42 | -2.72 |
Net Change In Cash & Equivalents | NA | -118.43 | -98.53 | 359.02 | 1,966.57 |
Cash at Beginning of Period | NA | 516.49 | 516.49 | 157.46 | 157.46 |
Cash at End of Period | NA | 398.05 | 417.96 | 516.49 | 2,124.04 |
Diluted Net EPS | 0.25 | 0.98 | 0.76 | 1.02 | 1.49 |